ConductScience.org, home

Paper35239089

Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy.

Lan A and 9 others. Int J Clin Oncol, 2022. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy. Papers, record 35239089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35239089

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy.
PubMed
Journal
Int J Clin Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.09
iCite
Revised in PubMed
2026-10-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lan AAilin
2Jin YYudi
3Wang YYu
4Wang YYihua
5Ding NNan
6Dai YYuran
7Jiang LLinshan
8Tang ZZhenrong
9Peng YYang
10Liu SShengchunhttps://orcid.org/0000-0002-9933-3643

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Neoadjuvant TherapyMajor topic
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Follicle Stimulating Hormone
Humans
Progesterone
Retrospective Studies
Testosterone

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
81772979National Natural Science Foundation of ChinaPubMed
81472658National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114710223Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study.Br J Cancer2004https://conductscience.org/library/papers/14710223PubMed
2133306Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.Obstet Gynecol1976https://conductscience.org/library/papers/133306PubMed
320961245Expression of follicle-stimulating hormone receptor in tumor blood vessels.N Engl J Med2010https://conductscience.org/library/papers/20961245PubMed
424074790Sex hormones and breast cancer risk and prognosis.Breast2013https://conductscience.org/library/papers/24074790PubMed
511350888Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer.Clin Cancer Res2001https://conductscience.org/library/papers/11350888PubMed
633538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
711959894Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.J Natl Cancer Inst2002https://conductscience.org/library/papers/11959894PubMed
825581441PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.Mol Pharm2015https://conductscience.org/library/papers/25581441PubMed
927435394Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.Clin Cancer Res2017https://conductscience.org/library/papers/27435394PubMed
1023283524Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.Breast Cancer Res Treat2013https://conductscience.org/library/papers/23283524PubMed
1129895278Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.BMC Cancer2018https://conductscience.org/library/papers/29895278PubMed
1216322344Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.Endocr Relat Cancer2005https://conductscience.org/library/papers/16322344PubMed
131674070Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer.Lancet1991https://conductscience.org/library/papers/1674070PubMed
1419903744Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.Endocr Relat Cancer2010https://conductscience.org/library/papers/19903744PubMed
1528527781Steroid metabolism in breast cancer: Where are we and what are we missing?Mol Cell Endocrinol2018https://conductscience.org/library/papers/28527781PubMed
1623688201Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases.BMC Cancer2013https://conductscience.org/library/papers/23688201PubMed
1729132557Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?Surg Oncol Clin N Am2018https://conductscience.org/library/papers/29132557PubMed
1821709140Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.Ann Oncol2011https://conductscience.org/library/papers/21709140PubMed
1921670457Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial.J Clin Oncol2011https://conductscience.org/library/papers/21670457PubMed
2031512725Progesterone and Breast Cancer.Endocr Rev2020https://conductscience.org/library/papers/31512725PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
36117838Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancer.Front Surg2022https://conductscience.org/library/papers/36117838

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35239089

GET https://conductscience.org/api/papers/v1/35239089/references?page=2